Evidence map›Paper›PMID 30523374›Full record

ReviewInternational urogynecology journal2019

IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.

S Abbas Shobeiri, M H Kerkhof, Vatche A Minassian, Tony Bazi, IUGA Research and Development Committee

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in International urogynecology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04636749 (Erbium Vaginal Laser for the Treatment of Stress Urinary Incontinence - Randomized Single Blind Trial), which is not on this map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04636749 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Erbium Vaginal Laser for the Treatment of Stress Urinary Incontinence - Randomized Single Blind Trial

TypeinterventionalSponsorRambam Health Care CampusRan2021 to 2022Enrolled80ConditionsStress Urinary IncontinenceArmsErbium laser, Sham laser
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Vaginal lasers for treating stress urinary incontinence in women.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. The efficacy of COLasers in medical science · 2023
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. COInternational urogynecology journal · 2022
    Trial
  8. Trial
  9. Trial
  10. Holistic Pelvic Floor: Pelvic Floor Stress Dysfunction Diseases.International urogynecology journal · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Joint Report on Terminology for Cosmetic Gynecology.International urogynecology journal · 2022
    Article
  17. Pixel-COLasers in medical science · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

S Abbas ShobeiriDepartment of Obstetrics and Gynecology, INOVA Women's Hospital, Falls Church, VA, USA. Abbas.Shobeiri@inova.org.
M H KerkhofCurilion Female Health Clinic, Haralem, Netherlands.
Vatche A MinassianDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.
Tony BaziDepartment of Obstetrics and Gynecology, The American University of Beirut, Beirut, Lebanon.
IUGA Research and Development Committee
American University of Beirut · LBBrigham and Women's Hospital · USGeorge Mason University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This committee opinion reviews the laser-based vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, and stress urinary incontinence. The United States Food and Drug Administration has issued a warning for unsubstantiated advertising and use of energy-based devices. Well-designed case-control studies are required to further investigate the potential benefits, harm, and efficacy of laser therapy in the treatment of genitourinary syndrome of menopause, vaginal laxity, and stress urinary incontinence. The therapeutic advantages of nonsurgical laser-based devices in urogynecology can only be recommended after robust clinical trials have demonstrated their long-term complication profile, safety, and efficacy.

Indexed as

Low-Level Light TherapyAtrophyFemaleHumansLasers, Solid-StateMenopauseSyndromeUrinary Incontinence, StressVaginaVaginal DiseasesVulvaEnergy-based devicesFDAGenitourinary syndrome of menopauseLaserStress urinary incontinenceVaginal laxity

Identifiers

PMID30523374
OpenAlexW2904728395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.